Dapsone therapy for hidradenitis suppurativa.

Abstract

British Journal of DermatologyVolume 183, Issue 4 p. 767-768 Research Letter Dapsone therapy for hidradenitis suppurativa G. Murray, Corresponding Author G. Murray murrgr@gmail.com orcid.org/0000-0003-3724-268X St Vincent's University Hospital, Elm Park, Dublin, IrelandSearch for more papers by this authorA. Hollywood, A. Hollywood St Vincent's University Hospital, Elm Park, Dublin, IrelandSearch for more papers by this authorB. Kirby, B. Kirby St Vincent's University Hospital, Elm Park, Dublin, Ireland Charles Institute of Dermatology, University College Dublin, Dublin, IrelandSearch for more papers by this authorR. Hughes, R. Hughes St Vincent's University Hospital, Elm Park, Dublin, Ireland Charles Institute of Dermatology, University College Dublin, Dublin, IrelandSearch for more papers by this author G. Murray, Corresponding Author G. Murray murrgr@gmail.com orcid.org/0000-0003-3724-268X St Vincent's University Hospital, Elm Park, Dublin, IrelandSearch for more papers by this authorA. Hollywood, A. Hollywood St Vincent's University Hospital, Elm Park, Dublin, IrelandSearch for more papers by this authorB. Kirby, B. Kirby St Vincent's University Hospital, Elm Park, Dublin, Ireland Charles Institute of Dermatology, University College Dublin, Dublin, IrelandSearch for more papers by this authorR. Hughes, R. Hughes St Vincent's University Hospital, Elm Park, Dublin, Ireland Charles Institute of Dermatology, University College Dublin, Dublin, IrelandSearch for more papers by this author First published: 15 April 2020 https://doi.org/10.1111/bjd.19136Citations: 4 Funding sources: none. Conflicts of interest: B.K. conducts clinical trials for AbbVie, Almirall, Merck Sharpe & Dohme, Novartis and UCB Pharma. B.K. is in receipt of research grants from AbbVie, Janssen and Almirall; he has acted as a consultant and/or speaker for AbbVie, Almirall, Janssen, LEO Pharma, Lilly, Novartis and UCB. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article.Citing Literature Volume183, Issue4October 2020Pages 767-768 RelatedInformation